From Recognition to Remedy: The Significance of Biomarkers in Neurodegenerative Disease Pathology

18Citations
Citations of this article
124Readers
Mendeley users who have this article in their library.
Get full text

Abstract

With the inexorable aging of the global populace, neurodegenerative diseases (NDs) like Alzheimer’s disease (AD), Parkinson’s disease (PD), and amyotrophic lateral sclerosis (ALS) pose escalating challenges, which are underscored by their socioeconomic repercussions. A pivotal aspect in addressing these challenges lies in the elucidation and application of biomarkers for timely diagnosis, vigilant monitoring, and effective treatment modalities. This review delineates the quintessence of biomarkers in the realm of NDs, elucidating various classifications and their indispensable roles. Particularly, the quest for novel biomarkers in AD, transcending traditional markers in PD, and the frontier of biomarker research in ALS are scrutinized. Emergent susceptibility and trait markers herald a new era of personalized medicine, promising enhanced treatment initiation especially in cases of SOD1-ALS. The discourse extends to diagnostic and state markers, revolutionizing early detection and monitoring, alongside progression markers that unveil the trajectory of NDs, propelling forward the potential for tailored interventions. The synergy between burgeoning technologies and innovative techniques like -omics, histologic assessments, and imaging is spotlighted, underscoring their pivotal roles in biomarker discovery. Reflecting on the progress hitherto, the review underscores the exigent need for multidisciplinary collaborations to surmount the challenges ahead, accelerate biomarker discovery, and herald a new epoch of understanding and managing NDs. Through a panoramic lens, this article endeavors to provide a comprehensive insight into the burgeoning field of biomarkers in NDs, spotlighting the promise they hold in transforming the diagnostic landscape, enhancing disease management, and illuminating the pathway toward efficacious therapeutic interventions.

References Powered by Scopus

Global, regional, and national burden of neurological disorders, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016

3269Citations
N/AReaders
Get full text

What are biomarkers?

1558Citations
N/AReaders
Get full text

Cerebrospinal fluid and plasma biomarkers in Alzheimer disease

1547Citations
N/AReaders
Get full text

Cited by Powered by Scopus

Proteomics profiling of extracellular vesicle for identification of potential biomarkers in Alzheimer's disease: A comprehensive review

5Citations
N/AReaders
Get full text

Innovative Therapeutic Strategies in Alzheimer’s Disease: A Synergistic Approach to Neurodegenerative Disorders

5Citations
N/AReaders
Get full text

Recent Advances in Therapeutics for the Treatment of Alzheimer’s Disease

4Citations
N/AReaders
Get full text

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

Toader, C., Dobrin, N., Brehar, F. M., Popa, C., Covache-Busuioc, R. A., Glavan, L. A., … Ciurea, A. V. (2023, November 1). From Recognition to Remedy: The Significance of Biomarkers in Neurodegenerative Disease Pathology. International Journal of Molecular Sciences. Multidisciplinary Digital Publishing Institute (MDPI). https://doi.org/10.3390/ijms242216119

Readers' Seniority

Tooltip

PhD / Post grad / Masters / Doc 11

69%

Lecturer / Post doc 4

25%

Professor / Associate Prof. 1

6%

Readers' Discipline

Tooltip

Biochemistry, Genetics and Molecular Bi... 5

29%

Pharmacology, Toxicology and Pharmaceut... 4

24%

Neuroscience 4

24%

Medicine and Dentistry 4

24%

Article Metrics

Tooltip
Mentions
Blog Mentions: 1
News Mentions: 2

Save time finding and organizing research with Mendeley

Sign up for free